NRF2 activation induces NADH-reductive stress providing a metabolic vulnerability in lung cancer
Tommy Weiss‐Sadan(Massachusetts General Hospital), Liron Bar‐Peled(Harvard University), Thales Papaginanakopoulos(NYU Langone Health), Lei Shi(Broad Institute), Makiko Hayashi(NYU Langone Health), Magdy Gohar(Massachusetts General Hospital), Junbing Zhang(Massachusetts General Hospital), Ting-Yu Wei(Massachusetts General Hospital), Charles H. Adelmann(The University of Texas MD Anderson Cancer Center), Marianne Richter(Massachusetts General Hospital), Mariko Takahashi(Massachusetts General Hospital), Maolin Ge(Shanghai Jiao Tong University), Tristan Vornbäumen(Massachusetts General Hospital), Vindhya Vijay(Broad Institute), David E. Fischer(Massachusetts General Hospital), Raúl Mostoslavsky(Massachusetts General Hospital), Alexander Carlin(Massachusetts General Hospital), Aaron N. Hata(Harvard University), Benedkit R. Dürr(Massachusetts General Hospital), Nabeel Bardeesy(Broad Institute), Hannah Fischer(Massachusetts General Hospital), Addriaan de Groot(Massachusetts General Hospital), Tzu-yi Yang(Massachusetts General Hospital)
Cited by 13
Related Papers
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
|Clinical Cancer Research|2016|1.2k
SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging
|Cell|2008|839
Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
|Nature|2015|788